1. Coronary Heart Disease

1. Coronary Heart Disease

<!-- translated-chunk:15/53 -->

Traditional Chinese medicine’s classical medical name for chest obstruction is similar to coronary heart disease. In the “Jin Gui,” nine prescriptions are listed for treating chest obstruction, including Gua Lou, Xie Bai, and Bai Jiu, with the focus of medication entirely on the qi level. Since the integration of traditional Chinese and Western medicine began, given that this disease is caused by atherosclerosis of the coronary vessels leading to luminal stenosis and insufficient blood supply—essentially falling under the category of blood stasis in TCM—treatment using methods to invigorate blood circulation and remove blood stasis has significantly improved therapeutic efficacy, providing a new approach to treating this condition. The Coronary Heart Disease No. 2 formula (red peony root, Sichuan lovage, safflower, agarwood, and salvia miltiorrhiza) formulated by the Beijing regional collaborative group is a particularly outstanding achievement in this regard. West Garden Hospital used this formula to treat 600 cases of angina pectoris due to coronary heart disease, achieving an overall effective rate of 90.7% and an ECG effective rate of 76.3%. Experimental studies have demonstrated that the Coronary Heart Disease No. 2 formula can lower blood lipids, reduce lipid infiltration in the arterial intima, enhance fibrinolysis, and inhibit platelet aggregation—actions that suppress the formation of atherosclerotic plaques. Additionally, this formula can dilate coronary vessels, protect against myocardial ischemia, relieve smooth muscle spasm, and enhance the body’s tolerance to hypoxia. All these effects are beneficial to normal cardiac physiological activity. The PLA 157th Hospital applied Mao Dongqing and Compound Mao Dongqing (with persimmon leaves and motherwort) to treat 274 cases of angina pectoris due to coronary heart disease, achieving an effective rate of 89.3%, a markedly effective rate of 60.7%, and an ECG effective rate of 76.6%. The Second Affiliated Hospital of Zhejiang Medical University used Salvia Miltiorrhiza No. 2 (salvia miltiorrhiza and Sichuan lovage) to treat this condition; after verification by several institutions, it showed an angina pectoris effective rate as high as 92.2% and an ECG effective rate of 33.8%. The Shanghai regional collaborative group also achieved good therapeutic results by using Compound Salvia Miltiorrhiza (salvia miltiorrhiza and agarwood) to treat this disease.